Search

Trailr2-cdh17-antibody-phase1-trial

Boehringer Ingelheim advances a bi-specific therapeutic antibody to first-in-human clinical trial for patients with advanced gastrointestinal cancers

Survey with Ipsos to gain insights human-animal bond

Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.

“Rare diseases are quite common”

Rare diseases are individually rare but collectively affect millions of people worldwide. Yet, they remain under-researched and are often misdiagnosed.

Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’ are now open for applications. The bi-annual awards reflect the long-term commitment to promoting the health and well-being of farm animals.

A tool to aid in the prevention of African swine fever

ASF COMBAT is an online management and biosecurity assessment tool aimed at reducing the African swine fever introduction risk level.

FreVAX smartphone application piglet vaccination

New FreVAX™ smartphone application brings piglet vaccination to another level

Partnership-with-clicktherapeutics

Boehringer Ingelheim collaborates with Click Therapeutics on prescription-based digital therapeutic to potentially aid in the treatment of schizophrenia

FOYA_Shanghai

Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”

2021 ABCD Young Scientist Award feline health

Young veterinary researchers Julia Klaus and Dr Yasmin Parr receive award for their work into feline SARS-CoV-2 infections and feline leukaemia virus.

Option to Acquire Trutino Biosciences

Partnership canine oncology

The collaboration will focus on identifying new molecules to target cancers in dogs. Small molecules could provide superior disease control.

sustainably fighting rabies info hub

Did you know that every nine minutes, rabies takes a human life? Find out how we support the elimination of this deadly disease.

World Rabies Day: BI fights rabies misconceptions

Boehringer Ingelheim joins efforts to fight rabies under this year’s theme for World Rabies Day to raise awareness of the disease and its prevention.

World Veterinary Day aspects veterinary profession

• World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated.

FDA approves Jardiance treatment chronic kidney disease

U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease

Veterinary oncology experts meet in Germany

Veterinary oncology experts meet prior to the European Society of Veterinary Oncology Congress in Hofheim, Germany

Boehringer Ingelheim reaches more patients than ever, innovation drives growth

Boehringer Ingelheim reports a strong performance in 2022.

Angels Initiative in South Africa

Dr Stacey Rossouw explains how the Angels initiative is making a difference in South Africa and optimizing stroke care

Over 100 billion birds vaccinated with VAXXITEK

Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.

Anna Race

Human Pharma's Sales Director for UK & Ireland, Anna Race discusses how she enjoys making a difference within the company.